COST-EFFECTIVENESS OF WARFARIN CARE BUNDLES AND NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION IN THAILAND

被引：0
|
作者：
Ng, S. S. [1 ]
Nathisuwan, S. [2 ]
Phrommintikul, A. [3 ]
Chaiyakunapruk, N. [4 ]
机构：
[1] Monash Univ Malaysia, Melaka, Malaysia
[2] Mahidol Univ, Bangkok, Thailand
[3] Chiang Mai Univ, Muang, Thailand
[4] Univ Utah, Salt Lake City, UT USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV55
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand
    Ng, Siok Shen
    Nathisuwan, Surakit
    Phrommintikul, Arintaya
    Chaiyakunapruk, Nathorn
    THROMBOSIS RESEARCH, 2020, 185 : 63 - 71
  • [2] Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
    Kansal, Anuraag R.
    Zheng, Ying
    Pokora, Tiffany
    Sorensen, Sonja V.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 225 - 237
  • [3] THE COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS FOR THE PREVENTION OF STROKE IN ATRIAL FIBRILLATION IN ENGLAND AND WALES
    Thom, H.
    Hollingworth, W.
    Bryden, P. A.
    Sterne, J.
    Bodalia, P. N.
    Davies, P.
    Lopez-Lopez, J. A.
    Okoli, G. N.
    Caldwell, D. M.
    Dias, S.
    Eaton, D.
    Higgins, J.
    Salisbury, C.
    Savovic, J.
    Sofat, R.
    Stephens-Boal, A.
    Hingorani, A.
    Welton, N. J.
    VALUE IN HEALTH, 2015, 18 (07) : A391 - A392
  • [4] Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysis
    You, Joyce H. S.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (01): : 6 - 14
  • [5] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    Current Cardiology Reports, 2015, 17
  • [6] Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation
    Ferreira, Joao
    Mirco, Ana
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (03) : 179 - 191
  • [7] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [8] COST-EFFECTIVENESS OF APIXABAN VERSUS OTHER NEW ORAL ANTICOAGULANTS AND WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN VENEZUELA
    Fernandez Avila, Y.
    Garcia, K. C.
    Garrido Lecca, S.
    Donato, B. M.
    Juarez-Garcia, A.
    VALUE IN HEALTH, 2015, 18 (07) : A829 - A829
  • [9] COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN CHINA
    Guo, W.
    Tian, X.
    Li, W.
    Han, S.
    VALUE IN HEALTH, 2018, 21 : S30 - S30
  • [10] Cost-effectiveness of apixaban against other novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation patients
    Lip, G. H. Y.
    Kongnakorn, T.
    Phatak, H.
    Kuznik, A.
    Rublee, D.
    Lanitis, T.
    Liu, L.
    Iloeje, U.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
12345